Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
NCT04895488Phase 3Recruiting
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jan 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vortioxetine in schizophrenia, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Jan 2022; status: recruiting.
02
Drugs
vortioxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04895488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04895488.